Objective: Studies of young relatives at elevated risk for schizophrenia have pointed to the importance of a variety of neurobiological, cognitive, and clinical risk factors for the disorder; yet few have employed integrated models to estimate the joint contribution of these factors to heightened schizophrenic risk. We tested the predictive power of an integrated psychobiological model of schizophrenia risk to subsequent psychopathology development among young relatives at risk for the disorder. Methods: Young first (n = 66) and second (n = 20) degree relatives of schizophrenia probands were followed for an average of 3 (SD = 1.13) years to examine their trajectories toward psychopathology development. Neurobiologic, cognitive, and clinical measures were employed in an integrated structural equation model to estimate their contribution to the prospective emergence of psychopathology. Results: Results indicated that neurobiological, neurocognitive, and psychosis proneness factors at baseline were all uniquely predictive of subsequent psychopathology development, and that an integrated model of psychopathology development that took into account these factors provided an excellent fit to the observed data. Subsequent classification analyses of model accuracy using likelihood ratios adjusting for the base-rate of psychopathology development in this sample revealed that individuals identified by this model had a 71% chance of developing psychopathology in the future. Conclusions: An integrated model of biobehavioral risk factors may provide a powerful method for predicting psychopathology and schizophrenia risk in at-risk samples. If validated, this model may be useful for early detection and intervention programs. Future research will need to focus particularly on predicting schizophrenia development and refining models to further enhance sensitivity.
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Introduction
The prediction of psychosis and related psychopathology has become a critical focus in schizophrenia research. Long-term premorbid studies of relatives at risk for schizophrenia are critical to closing in on the etiopathology of the disease and providing promising directions for the earliest of prevention and intervention strategies. Investigations of high risk samples have frequently observed cognitive, clinical, and neurobiologic deficits (Keshavan et al., 2005) . Studies of individuals at clinical high risk for schizophrenia have demonstrated greater decreases in brain volume, poorer neurocognitive performance on neuropsychological tests, and increased psychopathology in individuals who will eventually develop psychosis (Pantelis et al., 2003; Pukrop et al., 2007; Yung et al., 2004) . Unfortunately, few prospective studies have examined the contribution of such deficits toward heightened schizophrenia risk or the development of major psychopathology in young, at-risk relatives to elucidate the earliest risk markers for the disorder. Existing prospective investigations have frequently found early levels of psychopathology and psychosis proneness, brain abnormalities, and neurocognitive dysfunction to be longitudinal predictors of schizophrenia signs and symptoms (Johnstone et al., 2005; Lawrie et al., 2001; Sorensen et al., 2006) . However, to our knowledge, none have provided an integrated examination of the contribution of these related deficits.
It is unlikely that a single etiological factor is responsible for the development of schizophrenia, and interactions between variations in multiple genetic and environmental factors seem more plausible. Further, the predictive power of individual factors by themselves are not large (e.g., Sorensen et al., 2006 ). An integrative model that takes into 
